Medtech

 

What innovations are health tech investors most excited about in 2024?

Healthcare is a sector in which it can be hard to innovate. Regulations are tight and risk aversion is rife. This is understandable — justifiable, even — given lives are at stake. But it means the sector doesn’t see much creative destruction in the models it uses for delivering care. 
July 19, 2024

Exploring ‘dark labs’, at-home testing potential, and the diagnostic lab sector’s consolidation at HBI 2024

The global laboratory diagnostics market has grown significantly, with research estimating its value at around USD $210.58 billion in 2023. It is expected to reach approximately USD $284.38 billion by 2033, expanding at a CAGR of 3.05% from 2024 to 2033. This growth is driven by rising chronic diseases, an ageing population, and the increasing demand for early diagnostics. At HBI 2024, the panel 'Laboratory Diagnostics – Growth Beyond Consolidation' brought together industry experts.
July 3, 2024

Healthcare investment “through the bottom of the cycle” — Goldberg (Rothschild)

At last year’s conference Hedley Goldberg, Managing Director at multinational investment bank Rothschild, predicted healthcare M&A activity would begin picking up again in Q4 2023 or Q1 2024. But we’re now halfway through 2024 and there are still very few deals above €500m taking place. Goldberg is confident, however, that we have now passed through the bottom of the cycle.
June 20, 2024

Interview: Mohit Kumar, Ultrahuman

Ultrahuman is a medtech company that provides cutting-edge health-monitoring tools. It currently has four products: a smart ring, a continuous glucose monitoring wearable, a device that monitors air quality in the home and a blood-testing product. 
March 28, 2024

EU’s AI Act gets the greenlight from the European Commission

Despite opposition, the AI Act seems to be ploughing ahead right on schedule. This week, two key groups of lawmakers - the European Commission's civil liberties (LIBE) and internal market (IMCO) committees - gave their overwhelming support for the new law, which should come into force this summer.
February 16, 2024

Quadria investing $1.5bn into South and SE Asia

Singapore-based private equity firm Quadria Capital is set to inject $1.5bn worth of healthcare investments into South and South East Asian countries over the next two to three years. In line with growing trends, India stands to win big, earmarked to receive roughly 50% of the investment.
January 25, 2024
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us